US biotech Amgen (Nasdaq: AMGN) and Japanese partner Kyowa Kirin (TYO: 4151) announced new results from the ongoing ROCKET ...

South Korea-based Celltrion today announced that the US Food and Drug Administration (FDA) has approved Stoboclo and Osenvelt ...

The US Food and Drug Administration (FDA) has approved Celltrion’s biosimilars referencing Amgen’s bone disease therapy ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research shows ...

President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 27, 2025 /PRNewswire/ -- USA News Group News Commentary - Now that World Cancer Day (Feb.

Katie Goodale / USA TODAY NETWORK. Even if he is leaving home for Syracuse ... Outside of acting, Anthony is also focused on ...

Celltrion has received permission from the Food and Drug Administration for Stoboclo (CT-P41, denosumab-bmwo) and Osenvelt ...